SCHEMBL7859655

SCHEMBL7859655

CCN1C(=O)/C(=C/c2csc3ccc(Br)cc23)SC1=S

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.51
▸ KMT2A Q03164 7/20 0.51
▸ ALDH1A1 P00352 5/20 0.51
▸ MAPT P10636 5/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ IDE P14735 1/20 0.51
▸ ALOX12 P18054 1/20 0.51
▸ TNNI3 P19429 1/20 0.51
▸ TNNT2 P45379 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ TNNC1 P63316 1/20 0.51
▸ CYP2A6 P11509 1/20 0.47
▸ PDE4B Q07343 2/20 0.44
▸ PRF1 P14222 1/20 0.44
▸ DNM1 Q05193 1/20 0.43
▸ POLB P06746 3/20 0.42
▸ TP53 P04637 1/20 0.42
▸ GFER P55789 2/20 0.41
▸ NSD2 O96028 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1902258 0.86 KMT2A (0.57) MEN1KMT2APOLBGFERNSD2
SCHEMBL1902256 0.86 KMT2A (0.57) MEN1KMT2APOLBGFERNSD2
SCHEMBL1902254 0.86 KMT2A (0.57) MEN1KMT2APOLBGFERNSD2
SCHEMBL7859584 0.84 TDP1 (0.54) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL23578840 0.84 TDP1 (0.54) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL15761663 0.80 MEN1 (0.59) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL13726902 0.79 PDE4B (0.58) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL13726901 0.79 PDE4B (0.58) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL7859591 0.79 MEN1 (0.50) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL16210973 0.77 PDE4B (0.62) MEN1KMT2AALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE THE BURNHAM INSTITUTE (US) 2010-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016292-A1 INHIBITORS OF LETHAL FACTOR PROTEASE APAF1, F11, SERPINB1 MEN1 1839/4885KMT2A 3345/4885ALDH1A1 4227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback